The global market for Sequencing Reagents is estimated at US$6.3 Billion in 2023 and is projected to reach US$12.8 Billion by 2030, growing at a CAGR of 10.8% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the sequencing reagents market is driven by several factors. Firstly, the expanding applications of genomics in personalized medicine, disease diagnosis, and treatment are propelling the demand for high-quality sequencing reagents. Personalized medicine, which tailors medical treatment to the individual characteristics of each patient, relies heavily on genomic information to identify the best therapeutic strategies. The surge in genomic research, fueled by large-scale initiatives like the Human Genome Project and the more recent 100,000 Genomes Project, continues to generate significant demand for these reagents.
Advances in sequencing technologies, such as the development of more efficient NGS platforms, are also driving market growth by making sequencing more accessible and affordable. The increasing prevalence of genetic disorders and cancer has led to a rise in the use of sequencing in clinical settings, further boosting the market. Additionally, the growing use of sequencing in agricultural and environmental research is another factor contributing to market expansion. Pharmaceutical companies are increasingly using sequencing to identify new drug targets and to develop precision therapies. As these trends continue to evolve, the sequencing reagents market is poised for sustained growth and innovation, driven by technological advancements and expanding applications across various fields.
The growth in the sequencing reagents market is driven by several factors. Firstly, the expanding applications of genomics in personalized medicine, disease diagnosis, and treatment are propelling the demand for high-quality sequencing reagents. Personalized medicine, which tailors medical treatment to the individual characteristics of each patient, relies heavily on genomic information to identify the best therapeutic strategies. The surge in genomic research, fueled by large-scale initiatives like the Human Genome Project and the more recent 100,000 Genomes Project, continues to generate significant demand for these reagents.
Advances in sequencing technologies, such as the development of more efficient NGS platforms, are also driving market growth by making sequencing more accessible and affordable. The increasing prevalence of genetic disorders and cancer has led to a rise in the use of sequencing in clinical settings, further boosting the market. Additionally, the growing use of sequencing in agricultural and environmental research is another factor contributing to market expansion. Pharmaceutical companies are increasingly using sequencing to identify new drug targets and to develop precision therapies. As these trends continue to evolve, the sequencing reagents market is poised for sustained growth and innovation, driven by technological advancements and expanding applications across various fields.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Next Generation Sequencing Technology segment, which is expected to reach US$8.4 Billion by 2030 with a CAGR of a 11.3%. The Third Generation Sequencing Technology segment is also set to grow at 10.0% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $1.7 Billion in 2023, and China, forecasted to grow at an impressive 14.7% CAGR to reach $2.8 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Sequencing Reagents Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Sequencing Reagents Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Sequencing Reagents Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Agilent Technologies, Inc., BGI Group, F. Hoffmann-La Roche AG, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 86 Featured):
- Agilent Technologies, Inc.
- BGI Group
- F. Hoffmann-La Roche AG
- Illumina, Inc.
- Integrated DNA Technologies, Inc.
- Isogen Lifescience B.V.
- LGC Limited
- Meridian Bioscience, Inc.
- MGI Tech Co., Ltd.
- Pacific Biosciences of California, Inc.
- Promega Corporation
- QIAGEN GmbH
- Standard BioTools, Inc.
- Takara Bio, Inc.
- Thermo Fisher Scientific, Inc.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agilent Technologies, Inc.
- BGI Group
- F. Hoffmann-La Roche AG
- Illumina, Inc.
- Integrated DNA Technologies, Inc.
- Isogen Lifescience B.V.
- LGC Limited
- Meridian Bioscience, Inc.
- MGI Tech Co., Ltd.
- Pacific Biosciences of California, Inc.
- Promega Corporation
- QIAGEN GmbH
- Standard BioTools, Inc.
- Takara Bio, Inc.
- Thermo Fisher Scientific, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | September 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 6.3 Billion |
| Forecasted Market Value ( USD | $ 12.8 Billion |
| Compound Annual Growth Rate | 10.8% |
| Regions Covered | Global |
